IL298996A - Methods and preparations for the prevention and treatment of myopia (myopia) with pingolimod, a sphingosine-1-phosphate receptor modulator, and their derivatives - Google Patents

Methods and preparations for the prevention and treatment of myopia (myopia) with pingolimod, a sphingosine-1-phosphate receptor modulator, and their derivatives

Info

Publication number
IL298996A
IL298996A IL298996A IL29899622A IL298996A IL 298996 A IL298996 A IL 298996A IL 298996 A IL298996 A IL 298996A IL 29899622 A IL29899622 A IL 29899622A IL 298996 A IL298996 A IL 298996A
Authority
IL
Israel
Prior art keywords
fingolimod
sphingosine
derivatives
compositions
preventing
Prior art date
Application number
IL298996A
Other languages
English (en)
Hebrew (he)
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of IL298996A publication Critical patent/IL298996A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL298996A 2020-06-11 2021-06-09 Methods and preparations for the prevention and treatment of myopia (myopia) with pingolimod, a sphingosine-1-phosphate receptor modulator, and their derivatives IL298996A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063037910P 2020-06-11 2020-06-11
PCT/US2021/036628 WO2021252636A1 (en) 2020-06-11 2021-06-09 Methods and compositions for preventing and treating myopia with fingolimod, a sphingosine-1-phosphate receptor modulator, and derivatives thereof

Publications (1)

Publication Number Publication Date
IL298996A true IL298996A (en) 2023-02-01

Family

ID=78846511

Family Applications (1)

Application Number Title Priority Date Filing Date
IL298996A IL298996A (en) 2020-06-11 2021-06-09 Methods and preparations for the prevention and treatment of myopia (myopia) with pingolimod, a sphingosine-1-phosphate receptor modulator, and their derivatives

Country Status (7)

Country Link
EP (1) EP4164605A4 (de)
JP (1) JP2023530681A (de)
KR (1) KR20230051154A (de)
CN (1) CN116133665A (de)
CA (1) CA3182431A1 (de)
IL (1) IL298996A (de)
WO (1) WO2021252636A1 (de)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
JP2017507959A (ja) * 2014-03-13 2017-03-23 ボドール ラボラトリーズ， インコーポレイテッド 選択された抗コリン作動性両性イオンの使用
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
SG11202006255UA (en) * 2018-02-02 2020-07-29 Univ Kyoto Medicine for preventing or treating ophthalmic disease associated with enhanced intraocular neovascularization and/or intraocular vascular permeability

Also Published As

Publication number Publication date
EP4164605A4 (de) 2024-06-19
WO2021252636A1 (en) 2021-12-16
CN116133665A (zh) 2023-05-16
EP4164605A1 (de) 2023-04-19
CA3182431A1 (en) 2021-12-16
JP2023530681A (ja) 2023-07-19
KR20230051154A (ko) 2023-04-17

Similar Documents

Publication Publication Date Title
WO2015168618A3 (en) Compositions and methods for modulating growth hormone receptor expression
WO2007092190A3 (en) Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
EP3887351A4 (de) Verbindungen, zusammensetzungen und verfahren zur modulation von ferroptose und behandlung von exzitotoxischen störungen
ZA201904387B (en) Compositions and methods for treating, ameliorating and preventing h. pylori
EP3730614A3 (de) Modulatoren des wachstumshormonrezeptors
PH12019502174A1 (en) Modulators of pcsk9 expression
EP3998091A4 (de) Gewebezüchtungsmaterial zur reparatur von nervenläsionen, verfahren zu seiner herstellung und seine verwendung
IL287079A (en) Compositions and methods for regulating complement activity
WO2019147846A3 (en) Delivery system for aided replacement valve recapture and repositioning post- deployment
EP4164605A4 (de) Verfahren und zusammensetzungen zur prävention und behandlung von myopie mit fingolimod, einem sphingosin-1-phosphat-rezeptormodulator und derivaten davon
EP3822226A4 (de) Verpackter körper mit schwefelwasserstoff-retardmittel und verfahren zur herstellung davon und schwefelwasserstoff-retardmittel, schwefelwasserstoff-retardkörper und schwefelwasserstoffherstellungsverfahren mit verwendung davon
EP3891122A4 (de) Decarboxylase-inhibitoren zur behandlung von morbus parkinson
EP3760215A4 (de) Zusammensetzung zur vorbeugung, linderung oder behandlung von kachexie und muskelschwund
PT3851130T (pt) Formulação para injeção, contendo um conjugado de um material de enchimento de ácido poli-l-láctico e um material de enchimento de ácido hialurónico
GB202110228D0 (en) Compositions and methods for preventing or treating incontinence, overactive bladder, or menstrual cramping
EP3835061A4 (de) Folie zur landwirtschaftlichen verwendung, harzzusammensetzung zur formung einer folie zur landwirtschaftlichen verwendung und verfahren zur pflanzenzucht mit verwendung davon
EP3955927A4 (de) Zusammensetzungen und verfahren zur behandlung, linderung und vorbeugung von infektionen mit h. pylori
EP3834822C0 (de) Polymernanopartikelzusammensetzung zur abgabe von viren und verfahren zu ihrer herstellung
HUE054594T2 (hu) Bilasztint, béta-ciklodextrint és legalább egy gélesítõszert tartalmazó szemészeti kompozíciók
EP4053340A4 (de) Kunstrasen, füllstoff für kunstrasen und verfahren zur herstellung von kunstrasen
IL288491A (en) Methods for modulating a treatment regimen
EP4138841A4 (de) Formulierung zur behandlung von augenleiden
EP4108766A4 (de) Verfahren zur herstellung von fibroseverkapseltem tumoroid und verwendung davon
EP3885379A4 (de) Modifikator, modifiziertes konjugiertes dien-basiertes polymer damit und verfahren zur herstellung des polymers
EP3900714A4 (de) 4-phenylbutyrat enthaltendes mittel zur vorbeugung oder behandlung von presbyopie